Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Dividend History MGNX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Dividend Analytics MGNX

Max Ratio

5Y Dividend Growth

Consecutive Years

5Y Average Payout Ratio

Forward Annual Dividend Yield
Consecutive Years
Forward Annual Dividend – USD
Consistent Years
Dividend CAGR 3Y
Continuous Dividends
Dividend CAGR 5Y
Payout Ratio TTM
Dividend CAGR 10Y
Ex Dividend Date

MacroGenics Inc

MGNX
Current price
1.32 USD +0.02 USD (+1.54%)
Last closed 1.31 USD
ISIN US5560991094
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 82 648 288 USD
Yield for 12 month -70.67 %
1Y
3Y
5Y
10Y
15Y
MGNX
21.11.2021 - 28.11.2021

MacroGenics, Inc., a clinical-stage biopharmaceutical company, discovers, develops, manufactures, and commercializes antibody-based therapeutics to treat cancer in the United States. The company's product pipeline includes lorigerlimab, a bispecific DART molecule that targets checkpoint inhibitors PD-1 and CTLA-4 for the treatment of mCRPC and docetaxel that is in phase 2 clinical trials, as well as for the treatment of platinum-resistant ovarian cancer and clear cell gynecologic cancer which has completed phase 1 clinical trial; MGC026, an ADC that targets B7-H3 and delivers a novel topoisomerase I inhibitor (TOP1i)-based linker-payload; MGC028, an antibody-drug conjugates (ADC) that targets ADAM9 and delivers a novel TOP1i-based linker-payload for the treatment of solid tumors, which is in phase 1 clinical trials; MGC030, a ADC molecule for the treatment of solid tumors, which is in preclinical trials. It is also developing next generation T-cell engager programs. The company has collaborations with TerSera Therapeutics LLC; Incyte Corporation; and Gilead Sciences, Inc. MacroGenics, Inc. was incorporated in 2000 and is headquartered in Rockville, Maryland. Address: 9704 Medical Center Drive, Rockville, MD, United States, 20850

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

4.20 USD

P/E ratio

Dividend Yield

Financials MGNX

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Key Figures MGNX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Current Year

+148 339 000 USD

Last Year

+57 193 000 USD

Current Quarter

+13 192 000 USD

Last Quarter

+17 730 000 USD

Current Year

+136 040 000 USD

Last Year

+48 971 000 USD

Current Quarter

+7 792 000 USD

Last Quarter

+12 240 000 USD
EBITDA -91 982 000 USD
Operating Margin TTM -323.11 %
Price to Earnings
Return On Assets TTM -26.29 %
PEG Ratio 0.010
Return On Equity TTM -60.25 %
Wall Street Target Price 4.20 USD
Revenue TTM 154 050 000 USD
Book Value 1.25 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 44.90 %
Dividend Yield
Gross Profit TTM -38 981 000 USD
Earnings per share -0.88 USD
Diluted Eps TTM -0.88 USD
Most Recent Quarter I 2025
Quarterly Earnings Growth YOY 220.50 %
Profit Margin -36.23 %

Stock Valuation MGNX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 2.69
Price Sales TTM 0.56
Enterprise Value EBITDA -1.54
Price Book MRQ 1.09

Technical indicators MGNX

For 52 weeks

0.99 USD 5.77 USD
50 Day MA 1.50 USD
Shares Short Prior Month 6 093 652
200 Day MA 2.69 USD
Short Ratio 15.11
Shares Short 6 121 094
Short Percent 11.94 %